Boston Scientific Corporation (BSX), headquartered in Marlborough, Massachusetts, develops, manufactures, and markets medical ...

Johnson & Johnson said on Wednesday it has temporarily paused the rollout of its Varipulse heart device in the United States, ...

Alongside AI-driven and wearable technology, adaptive devices are contributing to a broader comprehensive framework for cardiac health management. A recent example of innovative solutions includes ...

Fire1 secured funding from investors including Medtronic to move forward with a clinical trial of its remote heart failure ...

Withings has announced both a blood pressure sensor device and a new heart health service called Cardio Check-Up as part of ...

is pump replacement through an artificial heart, called a left ventricular assist device, which can help the heart pump blood. "Skeletal muscle has a significant ability to regenerate after injury.

Johnson & Johnson’s JNJ MedTech unit has temporarily paused sales of Varipulse, its pulsed field ablation (PFA) therapy to treat atrial fibrillation (AFib) in the United States, as it ...

today announced a collaboration with AliveCor to develop Anumana’s advanced AI algorithms for early cardiac disease detection on AliveCor’s Kardia electrocardiogram (ECG) devices, starting ...

Introduction: Shoulder pain and disability ipsilateral to the implant site is a common complication of cardiac rhythm device implantation, yet very little has been published about this morbidity.

New Delhi: Adaptive cardiac devices are revolutionising heart disease treatment for real-time monitoring and dynamic therapy adjustments, according to a report. The report by GlobalData ...